Successful implementation of biosimilars through effective communication

Practical considerations for introducing biosimilars

How real-world data generation can assist biosimilar implementation

Regulatory principles for biosimilar medicines

Biologics utilisation and its efficiency through a hospital pharmacy centralised management system

The science of biosimilarity: Immunogenicity

Introduction of the biosimilar trastuzumab and its impact on patients and services

Practical guidance on the assessment of biosimilar monoclonal antibodies: A physician's perspective

Impact of cancer prevention campaigns in Brazil: A google trends analysis

Continuous treatment versus fixed duration therapy: Using real-world evidence to guide treatment paradigms for multiple myeloma

Transitioning from bortezomib to ixazomib in patients with multiple myeloma

Appraising an NTRK testing algorithm: When, what, how